Cardiogenics IC
Natural health product licensed in Canada
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80051532
- Status
- Active licence
- Licence date
- 6 June 2014
- Revision date
- 6 December 2017
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 51 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crataegus monogyna Source : Feuille et fleur Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 532 mg | 133 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 67 mg | 201,000 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 17 mcg | 51 µg |
| Terminalia arjuna Source : Écorce (tige) Extraction ratio : 5:1 Dry plant equivalent : 335 mg | 67 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, NA, Dioxyde de silicium, Hydroxypropylcellulose, Cellulose, Hypromellose, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor for the maintenance of good health. Used in herbal medicine to help maintain and/or support cardiovascular health in adults. Helps to maintain proper muscle function, including the heart muscle. Source of/An antioxidant that helps protect against oxidative stress. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking cardiac glycosides such as digitalis/digoxin, or blood pressure medication. If you are breastfeeding, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80051532
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging